CORBEVAX receives DCGI approval for Two Clinical Trials
Department of Biotechnology Mission COVID Suraksha Supported Biological E Limited Novel Covid-19 Vaccine candidate – CORBEVAX receives DCGI approval for Two Clinical Trials”. • Active controlled Phase III Clinical trial …
CORBEVAX receives DCGI approval for Two Clinical Trials Read More